Takeda Pharmaceutical Company (TAKN) Ratios
Takeda Pharmaceutical Company Ratios
MX:TAKN's free cash flow for Q2 2026 was $212.65B. For the 2026 fiscal year, MX:TAKN's free cash flow was decreased by $-44.54B and operating cash flow was $257.18B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.27 | 1.01 | 1.11 | 0.97 | 1.21 |
| Quick Ratio | 0.70 | 0.52 | 0.58 | 0.57 | 0.81 |
| Cash Ratio | 0.24 | 0.15 | 0.20 | 0.21 | 0.40 |
| Solvency Ratio | 0.12 | 0.12 | 0.10 | 0.13 | 0.11 |
| Operating Cash Flow Ratio | 0.43 | 0.42 | 0.31 | 0.39 | 0.52 |
| Short-Term Operating Cash Flow Coverage | 2.02 | 1.93 | 1.95 | 2.88 | 5.51 |
| Net Current Asset Value | $ -4.61T | $ -4.79T | $ -5.28T | $ -5.21T | $ -4.90T |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.32 | 0.32 | 0.31 | 0.33 |
| Debt-to-Equity Ratio | 0.63 | 0.65 | 0.67 | 0.69 | 0.76 |
| Debt-to-Capital Ratio | 0.39 | 0.39 | 0.40 | 0.41 | 0.43 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 0.36 | 0.38 | 0.39 | 0.42 |
| Financial Leverage Ratio | 1.99 | 2.05 | 2.08 | 2.20 | 2.32 |
| Debt Service Coverage Ratio | 1.46 | 1.67 | 3.35 | 2.69 | 3.40 |
| Interest Coverage Ratio | 1.51 | 2.49 | 201.49 | 4.19 | 3.76 |
| Debt to Market Cap | 0.53 | 0.63 | 0.75 | 0.65 | 0.80 |
| Interest Debt Per Share | 1676.81 | 1449.08 | 1548.41 | 1449.70 | 1428.79 |
| Net Debt to EBITDA | 3.13 | 3.41 | 3.83 | 3.00 | 2.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 51.06% | 65.51% | 66.43% | 69.11% | 68.99% |
| EBIT Margin | 13.71% | 9.80% | 11.71% | 15.39% | 16.81% |
| EBITDA Margin | 28.80% | 26.42% | 26.83% | 31.88% | 33.15% |
| Operating Profit Margin | 11.99% | 7.48% | 5.02% | 12.18% | 12.91% |
| Pretax Profit Margin | 5.77% | 3.82% | 1.24% | 9.31% | 8.48% |
| Net Profit Margin | 4.26% | 2.36% | 3.38% | 7.87% | 6.45% |
| Continuous Operations Profit Margin | 4.26% | 2.36% | 3.38% | 7.87% | 6.45% |
| Net Income Per EBT | 73.70% | 61.64% | 272.90% | 84.52% | 76.03% |
| EBT Per EBIT | 48.14% | 51.11% | 24.66% | 76.47% | 65.66% |
| Return on Assets (ROA) | 1.31% | 0.76% | 0.95% | 2.27% | 1.75% |
| Return on Equity (ROE) | 2.60% | 1.56% | 1.98% | 4.99% | 4.05% |
| Return on Capital Employed (ROCE) | 4.38% | 2.92% | 1.67% | 4.27% | 4.18% |
| Return on Invested Capital (ROIC) | 3.11% | 1.72% | 1.63% | 3.51% | 3.12% |
| Return on Tangible Assets | 3.25% | 2.04% | 2.66% | 6.47% | 4.65% |
| Earnings Yield | 2.20% | 1.51% | 2.22% | 4.67% | 4.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.43 | 6.32 | 6.11 | 5.91 | 4.93 |
| Payables Turnover | 4.74 | 5.12 | 4.47 | 4.05 | 3.74 |
| Inventory Turnover | 1.67 | 1.30 | 1.18 | 1.26 | 1.30 |
| Fixed Asset Turnover | 2.24 | 2.33 | 2.14 | 2.38 | 2.25 |
| Asset Turnover | 0.31 | 0.32 | 0.28 | 0.29 | 0.27 |
| Working Capital Turnover Ratio | 14.08 | 35.22 | 52.80 | 22.13 | 5.14 |
| Cash Conversion Cycle | 209.18 | 267.72 | 286.63 | 260.99 | 257.84 |
| Days of Sales Outstanding | 67.24 | 57.78 | 59.72 | 61.78 | 74.08 |
| Days of Inventory Outstanding | 218.97 | 281.18 | 308.49 | 289.42 | 281.35 |
| Days of Payables Outstanding | 77.04 | 71.25 | 81.58 | 90.20 | 97.59 |
| Operating Cycle | 286.21 | 338.96 | 368.21 | 351.20 | 355.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 330.60 | 329.27 | 228.94 | 314.84 | 359.16 |
| Free Cash Flow Per Share | 198.97 | 211.03 | 75.30 | 110.67 | 299.67 |
| Dividend Paid and CapEx Coverage Ratio | 1.43 | 1.55 | 0.93 | 1.07 | 2.39 |
| Capital Expenditure Coverage Ratio | 2.51 | 2.78 | 1.49 | 1.54 | 6.04 |
| Operating Cash Flow Coverage Ratio | 0.21 | 0.23 | 0.15 | 0.22 | 0.26 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.23 | 0.17 | 0.24 | 0.31 |
| Free Cash Flow Yield | 6.77% | 9.46% | 3.63% | 5.06% | 17.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 45.99 | 65.25 | 45.02 | 21.41 | 23.68 |
| Price-to-Sales (P/S) Ratio | 1.94 | 1.56 | 1.52 | 1.69 | 1.53 |
| Price-to-Book (P/B) Ratio | 1.19 | 1.03 | 0.89 | 1.07 | 0.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.77 | 10.57 | 27.53 | 19.77 | 5.81 |
| Price-to-Operating Cash Flow Ratio | 8.89 | 6.77 | 9.05 | 6.95 | 4.85 |
| Price-to-Earnings Growth (PEG) Ratio | 0.53 | -2.53 | -0.82 | 0.55 | -0.61 |
| Enterprise Value Multiple | 9.86 | 9.33 | 9.50 | 8.28 | 7.56 |
| Enterprise Value | 13.56T | 11.29T | 10.87T | 10.64T | 8.94T |
| EV to EBITDA | 9.86 | 9.33 | 9.50 | 8.28 | 7.56 |
| EV to Sales | 2.84 | 2.46 | 2.55 | 2.64 | 2.51 |
| EV to Free Cash Flow | 21.64 | 16.66 | 46.14 | 30.97 | 9.54 |
| EV to Operating Cash Flow | 13.02 | 10.68 | 15.18 | 10.89 | 7.96 |
| Tangible Book Value Per Share | -463.43 | -629.15 | -770.48 | -871.79 | -813.17 |
| Shareholders’ Equity Per Share | 2478.41 | 2159.98 | 2324.54 | 2047.33 | 1817.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.38 | -1.73 | 0.15 | 0.24 |
| Revenue Per Share | 1516.59 | 1426.96 | 1362.70 | 1297.67 | 1141.35 |
| Net Income Per Share | 64.55 | 33.61 | 46.04 | 102.14 | 73.57 |
| Tax Burden | 0.74 | 0.62 | 2.73 | 0.85 | 0.76 |
| Interest Burden | 0.42 | 0.39 | 0.11 | 0.61 | 0.50 |
| Research & Development to Revenue | 0.15 | 0.16 | 0.17 | 0.16 | 0.15 |
| SG&A to Revenue | 0.24 | 0.24 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| Income Quality | -6.85 | 9.78 | 4.97 | 3.08 | 4.88 |
Currency in JPY
